A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy

Acquired chemotherapy resistance is a major contributor to treatment failure in oncology. For example, the efficacy of the common anticancer agent doxorubicin (DOX) is limited by the emergence of multidrug resistance (MDR) phenotype in cancer cells. While dose escalation of DOX can circumvent such r...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pramanik, Dipankar, Campbell, Nathaniel R., Das, Samarjit, Gupta, Sonal, Chenna, Venugopal, Bisht, Savita, Sysa-Shah, Polina, Bedja, Djahida, Karikari, Collins, Steenbergen, Charles, Gabrielson, Kathleen L., Maitra, Amarnath, Maitra, Anirban
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2012
Témata:
Research Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3442295/
https://ncbi.nlm.nih.gov/pubmed/22791660
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky